On May 27, 2022 Herantis Pharma Plc ("Herantis"), developing disease modifying therapies for Parkinson’s disease, reported that interim CEO Frans Wuite will be presenting at the Redeye Growth Day on June 2th, 2022 (Press release, Herantis Pharma, MAY 27, 2022, View Source,c3575325 [SID1234615179]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Redeye Growth Day

The presentation will be live on the Redeye platform at 9:25 a.m. CEST

Follow this link to the event: Redeye Growth Day.

The presentations will be available via digital libraries, which are accessible to event participants only.

Please contact the conference organizers, or send an email to [email protected], if you wish to schedule a meeting with Herantis.